The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3913812)

Published in J Clin Endocrinol Metab on November 25, 2013

Authors

Muhammad Amer1, Rehan Qayyum

Author Affiliations

1: Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21287.

Articles cited by this

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29

25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50

Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr (2008) 6.26

Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med (1991) 6.03

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet (2007) 4.74

Vitamin D physiology. Prog Biophys Mol Biol (2006) 4.13

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (1997) 3.87

Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27

Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol (2011) 2.83

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke (2002) 2.56

Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost (2005) 1.99

Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology (2002) 1.92

Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol (2010) 1.64

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int (2006) 1.60

Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol (2009) 1.45

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr (1993) 1.36

MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr (2011) 1.31

Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem (2004) 1.24

1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine (2009) 1.20

The role of cystathionine beta-synthase in homocysteine metabolism. Antioxid Redox Signal (2005) 1.20

Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res (2012) 1.18

Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17

Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B (2010) 1.17

Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation (2000) 1.00

1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. J Bone Miner Res (2011) 0.97

Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood (1998) 0.91

Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. J Nutr (2004) 0.90

Relationship between 25-hydroxyvitamin D and all-cause and cardiovascular disease mortality. Am J Med (2013) 0.86

Articles by these authors

Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol (2011) 2.83

Effectiveness of continuing medical education. Evid Rep Technol Assess (Full Rep) (2007) 2.61

Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol (2010) 1.46

Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials. J Hosp Med (2011) 1.41

Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood (2011) 1.13

The reported validity and reliability of methods for evaluating continuing medical education: a systematic review. Acad Med (2008) 1.03

Outcome of cardiopulmonary resuscitation - predictors of survival. J Coll Physicians Surg Pak (2008) 1.01

Effect of obesity on platelet reactivity and response to low-dose aspirin. Prev Cardiol (2010) 1.00

Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network. Hum Mol Genet (2013) 0.97

Relationship between 25-hydroxyvitamin D and all-cause and cardiovascular disease mortality. Am J Med (2013) 0.86

Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis. Thromb Haemost (2008) 0.82

Comparison of Hospital Consumer Assessment of Healthcare Providers and Systems patient satisfaction scores for specialty hospitals and general medical hospitals: confounding effect of survey response rate. J Hosp Med (2014) 0.81

Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease. Thromb Res (2009) 0.79

25-Hydroxyvitamin D and ankle-brachial blood pressure index in adults without peripheral artery disease. Clin Transl Sci (2014) 0.77

Efficacy of Interventions to Reduce Resident Physician Burnout: A Systematic Review. J Grad Med Educ (2017) 0.75

Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population. Breast Cancer Res Treat (2015) 0.75

The Effect of Serum Vitamin D on Serum ALT Levels in Healthy Individuals. J Clin Gastroenterol (2016) 0.75

Serum alanine aminotransferase levels and all-cause mortality. Eur J Gastroenterol Hepatol (2016) 0.75